Genotype frequencies
. | White patients . | . | White controls . | . | . | Black patients . | . | Black controls . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XPD751 . | N . | % . | N . | % . | P* . | N . | % . | N . | % . | P† . | ||||
AA | 116 | 37.1 | 183 | 42.4 | .167 | 20 | 52.6 | 87 | 59.6 | .555 | ||||
AC | 142 | 45.4 | 194 | 44.9 | .960 | 18 | 47.4 | 52 | 35.6 | .254 | ||||
CC | 55 | 17.6 | 55 | 12.7 | .083 | 0 | 0 | 7 | 4.8 | .348 |
. | White patients . | . | White controls . | . | . | Black patients . | . | Black controls . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XPD751 . | N . | % . | N . | % . | P* . | N . | % . | N . | % . | P† . | ||||
AA | 116 | 37.1 | 183 | 42.4 | .167 | 20 | 52.6 | 87 | 59.6 | .555 | ||||
AC | 142 | 45.4 | 194 | 44.9 | .960 | 18 | 47.4 | 52 | 35.6 | .254 | ||||
CC | 55 | 17.6 | 55 | 12.7 | .083 | 0 | 0 | 7 | 4.8 | .348 |